ILEX Oncology IPO priced at $ 12 / shr . ILEX Oncology Inc said Friday its 2 . 5 million share initial public offering was priced at $ 12 per share . The company said it plans to use a majority of the net proceeds to fund internal product development in cancer prevention compounds , expansion of its drug development capacity and capabilities , and expansion of its portfolio of compounds . Salomon Brothers was the lead manager and Cowen & Co and Smith Barney were co - managers of the offering . 
